Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Classical hematology 2Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myeloid, Acute 12Anemia, Refractory, with Excess of Blasts 12Neoplasms 9Myelodysplastic Syndromes 9Venous Thromboembolism 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Anemia, Aplastic 5Myeloproliferative Disorders 4Lymphoma, Non-Hodgkin 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Fanconi Anemia 4Anemia 4Thrombocytopenia 3Pulmonary Embolism 3Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Multiple Myeloma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hodgkin Disease 3Congenital Bone Marrow Failure Syndromes 3Burkitt Lymphoma 3Blast Crisis 3Anemia, Sickle Cell 3Venous Thrombosis 2Uterine Cervical Neoplasms 2Recurrence 2Pathologic Complete Response 2

Interventions

Tretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pathologic Complete Response × Classical hematology × 30 days × Clear all
NCT07586813 2026-05-14

N01-A-PICIT-GI

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
Classical hematologyGastrointestinal

Pathologic Complete Response, Digestive System Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Thrombocytopenia, Colorectal Neoplasms

NCT07586826 2026-05-14

N01-A-PICIT-GT

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡